|
|
||||||||
Ann Thorac Surg 2002;74:1438-1442
© 2002 The Society of Thoracic Surgeons
a Department of Cardiovascular Surgery, Berlin, Germany
b Department of Radiology, Charité, Humboldt University Berlin, Berlin, Germany
Accepted for publication June 7, 2002.
* Address reprint requests to Dr Dohmen, Department of Cardiovascular Surgery, Charité, Humboldt University Berlin, Schumannstrasse 20/21, D-10117 Berlin, Germany
e-mail: pascal.dohmen{at}charite.de
Background. The Ross procedure has gained increasing acceptance due to excellent hemodynamic results by replacing the diseased aortic valve with the viable autologous pulmonary valve. Consequently, the right ventricular outflow tract (RVOT) has to be reconstructed. In this report a viable heart valve was created from decellularized cryopreserved pulmonary allograft that was seeded with viable autologous vascular endothelial cells (AVEC).
Methods. A 43-year-old patient suffering from aortic valve stenosis underwent a Ross operation on May 20, 2000, using a tissue engineered (TE) pulmonary allograft to reconstruct the RVOT. Four weeks before the operation a piece of forearm vein was harvested to separate, culture, and characterize AVEC. Follow-up was completed at discharge, 3, 6, and 12 months postoperatively by clinical evaluation, transthoracic echocardiography (TTE), and magnetic resonance imaging (MRI). Additionally, at 1-year follow-up a multislice computed tomographic scan was performed.
Results. After four weeks of culturing 8.34x106 AVEC were available to seed a 27-mm decellularized pulmonary allograft. Trypan blue staining confirmed 96.0% viability. Reendothelialization rate after seeding was 9.0x105 cells/cm2. TTE and MRI revealed excellent hemodynamic function of the TE heart valve and the neoaortic valve as well. Multislice computed tomography revealed no evidence of valvular calcification.
Conclusions. After 1 year of follow-up the patient is in excellent condition without limitation and exhibits normal aortic and pulmonary valve function.
This article has been cited by other articles:
![]() |
P. M. Dohmen and W. Konertz Decellularization of Xenogenic Biologic Tissue Ann. Thorac. Surg., June 1, 2008; 85(6): 2163 - 2163. [Full Text] [PDF] |
||||
![]() |
P. M. Dohmen, A. Lembcke, S. Holinski, D. Kivelitz, J. P. Braun, A. Pruss, and W. Konertz Mid-Term Clinical Results Using a Tissue-Engineered Pulmonary Valve to Reconstruct the Right Ventricular Outflow Tract During the Ross Procedure Ann. Thorac. Surg., September 1, 2007; 84(3): 729 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T Butcher and R. M Nerem Valvular endothelial cells and the mechanoregulation of valvular pathology Phil Trans R Soc B, August 29, 2007; 362(1484): 1445 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hayashida, K. Kanda, H. Yaku, J. Ando, and Y. Nakayama Development of an in vivo tissue-engineered, autologous heart valve (the biovalve): Preparation of a prototype model J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 152 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Gabbieri, P. M. Dohmen, J. Linneweber, A. Lembcke, J. P. Braun, and W. Konertz Ross procedure with a tissue-engineered heart valve in complex congenital aortic valve disease J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1088 - 1089. [Full Text] [PDF] |
||||
![]() |
G. Van Nooten, P. Somers, M. Cornelissen, S. Bouchez, F. Gasthuys, E. Cox, L. Sparks, and K. Narine Acellular porcine and kangaroo aortic valve scaffolds show more intense immune-mediated calcification than cross-linked Toronto SPV(R) valves in the sheep model Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 544 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Bohm, C. A. Botha, A. Horke, W. Hemmer, D. Roser, G. Blumenstock, F. Uhlemann, and J.-G. Rein Is the Ross operation still an acceptable option in children and adolescents? Ann. Thorac. Surg., September 1, 2006; 82(3): 940 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Dohmen and W. Konertz Seeding human endothelial cells on complex three-dimensional scaffolds. Ann. Thorac. Surg., May 1, 2006; 81(5): 1942 - 1942. [Full Text] [PDF] |
||||
![]() |
K. J. Zehr, M. Yagubyan, H. M. Connolly, S. M. Nelson, and H. V. Schaff Aortic root replacement with a novel decellularized cryopreserved aortic homograft: Postoperative immunoreactivity and early results J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1010 - 1015. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Meyer, J. Nagendran, L. S. Desai, G. R. Rayat, T. A. Churchill, C. C. Anderson, R. V. Rajotte, J. R.T. Lakey, and D. B. Ross Decellularization reduces the immune response to aortic valve allografts in the rat J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 469 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rieder, G. Seebacher, M.-T. Kasimir, E. Eichmair, B. Winter, B. Dekan, E. Wolner, P. Simon, and G. Weigel Tissue Engineering of Heart Valves: Decellularized Porcine and Human Valve Scaffolds Differ Importantly in Residual Potential to Attract Monocytic Cells Circulation, May 31, 2005; 111(21): 2792 - 2797. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Grauss, M. G. Hazekamp, F. Oppenhuizen, C. J. van Munsteren, A. C. Gittenberger-de Groot, and M. C. DeRuiter Histological evaluation of decellularised porcine aortic valves: matrix changes due to different decellularisation methods Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 566 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Affonso da Costa, P. M. Dohmen, D. Duarte, C. von Glenn, S. V. Lopes, H. H. Filho, M. B. Affonso da Costa, and W. Konertz Immunological and echocardiographic evaluation of decellularized versus cryopreserved allografts during the Ross operation Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 572 - 578. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takabayashi, H. Kado, Y. Shiokawa, K. Fukae, and T. Nakano Modified Ross procedure using a conduit with a synthetic valve Eur. J. Cardiothorac. Surg., December 1, 2004; 26(6): 1087 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Grauss, M. G. Hazekamp, S. van Vliet, A. C. Gittenberger-de Groot, and M. C. DeRuiter Decellularization of rat aortic valve allografts reduces leaflet destruction and extracellular matrix remodeling J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 2003 - 2010. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Konertz Stentless Aortic Xenograft Heart Valves Asian Cardiovasc Thorac Ann, March 1, 2003; 11(1): 1 - 2. [Full Text] [PDF] |
||||
![]() |
R. C. Elkins Tissue-engineered valves Ann. Thorac. Surg., November 1, 2002; 74(5): 1434 - 1434. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |